Today's Daily Dose brings you news about BioSig Technologies' foray into COVID-19 drug development, FDA approval of Bristol-Myers' multiple sclerosis drug, delay in FDA panel review of Intercept Pharma's NASH drug candidate, and positive results of VBL Therapeutics' ovarian cancer trial.
from RTT - Biotech https://ift.tt/2vVGdvK
via IFTTT
The great thing about this post is quality information. I always like to read amazingly useful and quality content. Your article is amazing, thank you for sharing this article.
ReplyDeleteForex Trading
Forex Market
Foreign Exchange Market